Filter
732
Filtered Results: 732
Text search:
antimalarial
drugs
Featured
Recommendations
76
New Publications
259
Language
Document type
No document type
421
Studies & Reports
104
Guidelines
93
Manuals
40
Strategic & Response Plan
25
Training Material
21
Fact sheets
16
Situation Updates
4
App
2
Resource Platforms
2
Infographics
2
Brochures
1
Videos
1
Countries / Regions
Uganda
41
India
38
Sierra Leone
32
Global
31
Kenya
30
Nigeria
27
Ghana
25
Ethiopia
24
Liberia
24
Malawi
21
Tanzania
20
Rwanda
17
Zambia
16
Nepal
12
Senegal
12
Latin America and the Carribbean
12
Africa
11
Cameroon
9
Philippines
8
South Africa
8
Namibia
8
Zimbabwe
7
Bangladesh
7
Burkina Faso
6
Mozambique
6
Cambodia
6
South–East Asia Region
6
Myanmar / Burma
6
Indonesia
5
Thailand
4
Congo, Democratic Republic of
4
Vietnam
4
Western and Central Europe
3
North America
3
East and Southern Africa
3
Papua New Guinea
3
Brazil
3
Central African Republic
3
Botswana
3
South Sudan
3
Eswatini/ Swaziland
3
Laos
2
Guinea
2
Haiti
2
Asia
2
Venezuela
2
West and Central Africa
2
Middle East and North Africa
2
Chad
2
Somalia
2
Pakistan
2
Colombia
1
Timor Leste/ East Timor
1
El Salvador
1
Lesotho
1
Turkey
1
Benin
1
Gambia
1
Togo
1
China
1
Chile
1
Burundi
1
Peru
1
Dominican Republic
1
Eastern Europe and Central Asia
1
Turkmenistan
1
France
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Argentina
1
Lebanon
1
Eastern Europe
1
Nicaragua
1
Sri Lanka
1
Sudan
1
Honduras
1
Mali
1
Libya
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
395
Clinical Guidelines
71
Women & Child Health
44
Public Health
24
Key Resources
24
Capacity Building
15
Pharmacy & Technologies
14
Toolboxes
Malaria
100
AMR
39
Pharmacy
38
Ebola & Marburg
24
NTDs
21
HIV
15
Rapid Response
12
Caregiver
10
TB
9
COVID-19
9
Health Financing Toolbox
6
Mental Health
5
Planetary Health
5
Disability
4
Conflict
4
Refugee
3
Global Health Education
3
Natural Hazards
2
Polio
2
Cholera
1
Zika
1
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
Master of Science in Pharmaceutical Management Dissertation
The webpage from Medicines for Malaria Venture (MMV) focuses on efforts to develop and provide child-friendly antimalarial treatments. It highlights the challenges of treating malaria in children, who are among the most vulnerable to the disease, and the need for safe, effective, and easy-to-adminis...
EXPERT OPINION ON DRUG SAFETY 2018, VOL. 17, NO. 11, 1129–1144.
Malaria during and after pregnancy contributes significantly to maternal mortality and adverse fetal outcomes. While effective and safe antimalarial treatments are essential, quinine — an older, less effective drug — has long bee...
Infection and Drug Resistance 2020:13 4047–4060
Launch of the WHO Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019). Key findings
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
Meeting report, Kampala, Uganda,
7–8 November 2023
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
The WorldWide Antimalarial Resistance Network (WWARN) is a global collaborative platform that provides the malaria community with innovative tools and reliable evidence to help them understand and address antimalarial drug resistance. Using molecular surveyors and mapping tools, WWARN visualises the...
Efficacious antimalarial medicines are critical to malaria control and elimination. Continuous monitoring of their efficacy is needed to inform treatment policies in malaria-endemic countries, and to ensure early detection of, and response to, drug resistance.
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
The WHO Malaria Threats Map is an interactive online platform that showcases the latest global data on four critical biological threats to effective malaria control and elimination: mosquito insecticide resistance, Plasmodium falciparum hrp2/3 gene deletions, antimalarial drug resistance, and the ...
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re...
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis a...
The USAID | DELIVER PROJECT, Task Order 4, developed this guide for quantifying health commodities; it will assist technical advisors, program managers, warehouse managers, procurement officers, and service providers in (1) estimating the total commodity needs and costs for successful implementation...
